Glenmark introducing Remogliflozin + Vildagliptin combination first time in India
Glenmark Pharmaceuticals Limited is introducing a fixed dose combination (FDC) of Remogliflozin + Vildagliptin. Remogliflozin is Sodium Glucose Co-Transporter Inhibitor (SGLT2i). Sodium/glucose... Read More
Glenmark to introduce SGLT2 inhibitor Remogliflozin in India by licesning collaboration with BHV Pharma
Glenmark Pharmaceuticals is bringing to India Remogliflozin etabonate, a drug used to treat adults with Type 2 diabetes. Glenmark did the phase... Read More